LON:OXP - Oxford Pharmascience Group Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseGBX 1.48
Today's RangeGBX 1.44 - GBX 1.44
52-Week RangeGBX 1.12 - GBX 3.30
Volume16,260 shs
Average Volume803,502 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Oxford Pharmascience Group plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in re-developing medicines. The Company primarily engages in research and development activities based around its core technology platforms and focuses on commercializing the related products to pharmaceutical organizations. It operates through one segment, being the development and commercialization of drug products from proprietary technology platforms. The Company operates in three main geographic areas, such as the United Kingdom, Middle East and Brazil. The Company is primarily focused on commercialization efforts for its compounds OXPzero Ibuprofen and OXPzero Naproxen and in regulatory, technical and clinical activities in support of these assets. It is focused on establishing a number of commercial partnerships that demonstrate the commercial feasibility of the technology. The Company's subsidiaries include Oxford Pharmascience Limited and Oxford Nutra Limited.

Receive OXP News and Ratings via Email

Sign-up to receive the latest news and ratings for OXP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
Phone+44-20-75545875

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
OptionableNot Optionable

Oxford Pharmascience Group (LON:OXP) Frequently Asked Questions

What is Oxford Pharmascience Group's stock symbol?

Oxford Pharmascience Group trades on the London Stock Exchange (LON) under the ticker symbol "OXP."

Has Oxford Pharmascience Group been receiving favorable news coverage?

News coverage about OXP stock has been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Oxford Pharmascience Group earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days.

Who are Oxford Pharmascience Group's key executives?

Oxford Pharmascience Group's management team includes the folowing people:
  • Marcelo Leonardo Bravo, Chief Executive Officer, Executive Director
  • Christopher Hill, Chief Financial Officer, Executive Director, Company Secretary
  • David Robert Norwood, Non-Executive Chairman of the Board (Age 48)
  • James Nicholas Gerald White, Non-Executive Deputy Chairman of the Board
  • John Geoffery Goddard, Independent Non-Executive Director
  • Karl Robertson Van Horn, Independent Non-Executive Director (Age 80)

How do I buy shares of Oxford Pharmascience Group?

Shares of OXP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Oxford Pharmascience Group's official website?

The official website for Oxford Pharmascience Group is http://www.oxfordpharmascience.com/.

How can I contact Oxford Pharmascience Group?

Oxford Pharmascience Group's mailing address is 2 Royal College Street, LONDON, NW1 0NH, United Kingdom. The company can be reached via phone at +44-20-75545875.


MarketBeat Community Rating for Oxford Pharmascience Group (LON OXP)

Community Ranking:  1.4 out of 5 (star)
Outperform Votes:  86 (Vote Outperform)
Underperform Votes:  221 (Vote Underperform)
Total Votes:  307
MarketBeat's community ratings are surveys of what our community members think about Oxford Pharmascience Group and other stocks. Vote "Outperform" if you believe OXP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OXP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2019 by MarketBeat.com Staff

Featured Article: What are retained earnings?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel